3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
104
INDUSTRY
29
NIH
17
NETWORK
11
UNKNOWN
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Brain Neoplasms
2
Meningeal Carcinomatosis
1
Leiomyosarcoma
1
Extrapancreatic Neuroendocrine Tumor
1
Adenoma, Islet Cell
1
Interventions
Temozolomide
2
Radiotherapy, Intensity-Modulated
2
pyrotinib
1
Vinorelbine
1
Radiation Dose Hypofractionation
1
Pharmaceutical Preparations
1
Gefitinib
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
UNKNOWN
×
Brain Neoplasms
×
Temozolomide
×
Clear all
NCT03778541
2019-07-23
HFSRT With Concurrent TMZ for Large BMs
ChineseAMS
Phase 3
Unknown
224 enrolled
NCT02654106
2017-06-06
SRTRBM
ChineseAMS
Phase 2
Completed
65 enrolled